BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 16598465)

  • 1. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
    van Ipenburg JA; de Waard NE; Naus NC; Jager MJ; Paridaens D; Verdijk RM
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2950-2957. PubMed ID: 31305861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding of conjunctival melanocytic pigmented lesions within pterygium.
    Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
    Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brown cornea.
    Steiber Z; Ehlers N; Heegaard S; Hjortdal J; Berta A; Prause JU
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):537-41. PubMed ID: 18193447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pigmented conjunctival lesions.
    Oellers P; Karp CL
    Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival nevus and melanoma.
    Furdova A; Pesko K; Strmen P; Kobzova M
    Bratisl Lek Listy; 2007; 108(7):287-91. PubMed ID: 17972544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
    Harooni H; Schoenfield LR; Singh AD
    Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
    Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
    Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
    Jiang K; Brownstein S; Lam K; Burns B; Farmer J
    JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
    McDonnell JM; Sun YY; Wagner D
    Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.